BioSig Confirms NASDAQ Listing for Common Stock
Ticker: STEX · Form: 8-K · Filed: Feb 6, 2024 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 8-K |
| Filed Date | Feb 6, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, stock-listing, corporate-governance
TL;DR
**BioSig's common stock remains listed on NASDAQ under BSGM.**
AI Summary
BioSig Technologies, Inc. filed an 8-K on February 6, 2024, primarily to disclose that its common stock, with a par value of $0.001 per share, is registered on The NASDAQ Capital Market under the trading symbol BSGM. This filing is a routine update, confirming the company's compliance with SEC regulations and its listing status. For investors, this matters because it reaffirms the stock's continued liquidity and visibility on a major exchange, which is crucial for trading and investor confidence.
Why It Matters
This filing confirms BioSig's continued listing on The NASDAQ Capital Market, ensuring the stock remains accessible for trading and maintaining market transparency.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure confirming existing information and does not introduce new risks or significant changes to the company's operations or financial health.
Analyst Insight
This filing is routine and confirms existing information. A smart investor would note the continued NASDAQ listing but recognize that this specific 8-K does not provide new material information to warrant immediate action or change investment thesis.
Key Numbers
- $0.001 — par value per share (standardized value for each share of common stock)
Key Players & Entities
- BioSig Technologies, Inc. (company) — the registrant filing the 8-K
- The NASDAQ Capital Market (company) — the exchange where BioSig's common stock is registered
- $0.001 (dollar_amount) — par value per share of common stock
- BSGM (company) — trading symbol for BioSig Technologies, Inc. common stock
- February 6, 2024 (date) — date of earliest event reported and filing date
FAQ
What is the primary purpose of this 8-K filing by BioSig Technologies, Inc.?
The primary purpose of this 8-K filing, dated February 6, 2024, is to report the current status of BioSig Technologies, Inc.'s common stock, specifically its registration on The NASDAQ Capital Market under the trading symbol BSGM, and to satisfy Regulation FD Disclosure requirements.
On which stock exchange is BioSig Technologies, Inc.'s common stock registered?
BioSig Technologies, Inc.'s common stock, with a par value of $0.001 per share, is registered on The NASDAQ Capital Market.
What is the trading symbol for BioSig Technologies, Inc. common stock?
The trading symbol for BioSig Technologies, Inc. common stock is BSGM.
What is the par value of BioSig Technologies, Inc.'s common stock as stated in the filing?
The par value of BioSig Technologies, Inc.'s common stock is $0.001 per share.
What was the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was February 6, 2024.
Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-02-06 08:35:41
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share BSGM The NASDAQ Capital M
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 22KB
- ex99-1_001.jpg (GRAPHIC) — 4KB
- 0001493152-24-005030.txt ( ) — 242KB
- bsgm-20240206.xsd (EX-101.SCH) — 3KB
- bsgm-20240206_lab.xml (EX-101.LAB) — 33KB
- bsgm-20240206_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIOSIG TECHNOLOGIES, INC. Date: February 6, 2024 By: / s/ Kenneth L. Londoner Name: Kenneth L. Londoner Title: Executive Chairman